The Suspect in the J6 Pipe Bombing Incident Has Been Captured. Why the...
A Newsom Nihilist Nomination?
The Importance of Being Earnest
Media Make 'Venezuelan Fishermen' the New 'Maryland Father,' and Covering Up the Minnesota...
New Mexico Democrats Push Bill Based on Results of Idiotic Study
Israeli Prime Minister Says He'll Happily Visit NYC Despite Mamdani's Threat to Uphold...
Climate Study That Shaped Global Policy Retracted After Major Error
Inside a Secret Transgender Health Conference: Clinicians Admit They're All Just 'Winging...
U.S. Secret Service Seized 16 Illegal Skimmers, Stopped $16M in Fraud
Two Men Charged After 1,585 Pounds of Meth Found Hidden in Blackberry Shipments...
SCOTUS Upholds New Texas Redistricting Map
Georgia CEO Gets Eight Years for Bribery Scheme Involving Honduran Police Contracts
Appeals Court Grants Administrative Stay to Keep National Guard in D.C.
Santa Monica Doctor Gets 30 Months for Illegally Supplying Ketamine to Actor Matthew...
The Day a Mall Became a Stage for a Hate Movement
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos